Literature DB >> 2754121

Isolated chronic mitral regurgitation with preserved systolic left ventricular function and severe pulmonary hypertension.

D Alexopoulos1, C Lazzam, S Borrico, L Fiedler, J A Ambrose.   

Abstract

Pulmonary hypertension in chronic mitral valve disease has been related most commonly to left ventricular dysfunction or mitral stenosis; its association with chronic, isolated mitral regurgitation and preserved left ventricular systolic function is unclear. In 41 catheterized patients with chronic mitral regurgitation (known history of mitral regurgitation for greater than 18 months) and preserved left ventricular systolic function (ejection fraction greater than 0.55), historic, electrocardiographic, echocardiographic and hemodynamic variables were analyzed. Ten patients (Group I) had normal pulmonary artery systolic pressure (less than 30 mm Hg), whereas 31 patients had pulmonary hypertension. Pulmonary artery systolic pressure was mildly increased (30 to 49 mm Hg) in 13 patients (Group II) and was greater than or equal to 50 mm Hg in 18 patients (Group III). Univariate analysis showed the more frequent occurrence of male gender and ruptured chordae tendineae in the groups with pulmonary hypertension. Mean pulmonary capillary wedge pressure, size of the V wave in pulmonary capillary wedge pressure and pulmonary arteriole resistance were higher, whereas cardiac index was lower in the hypertension groups. Multivariate stepwise analysis revealed higher mean pulmonary capillary wedge pressure and pulmonary arteriole resistance as the only variables independently differing among groups. In conclusion, pulmonary hypertension occurs frequently (76% of cases) in patients with chronic, isolated mitral regurgitation with preserved left ventricular systolic function. In these patients, a severe increase in pulmonary capillary wedge pressure is associated with elevation in pulmonary artery resistance, a finding similar to that in mitral stenosis.

Entities:  

Mesh:

Year:  1989        PMID: 2754121     DOI: 10.1016/0735-1097(89)90180-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Is pulmonary artery pressure a trigger of adverse outcome in mitral regurgitation?

Authors:  Iside Scarfò; Giovanni La Canna
Journal:  Ann Transl Med       Date:  2016-12

Review 2.  Epidemiology of pulmonary hypertension and right ventricular failure in left heart failure.

Authors:  Thenappan Thenappan; Mardi Gomberg-Maitland
Journal:  Curr Heart Fail Rep       Date:  2014-12

3.  How does severe functional mitral regurgitation redefined by European guidelines affect pulmonary vascular resistance and hemodynamics in heart transplant candidates?

Authors:  Zübeyde Bayram; Cem Doğan; Rezzan Deniz Acar; Süleyman Efe; Özgür Yaşar Akbal; Fatih Yılmaz; Büşra Güvendi Şengör; Ahmet Karaduman; Samet Uysal; Ali Karagöz; Çağatay Önal; Mehmet Kaan Kırali; Cihangir Kaymaz; Nihal Özdemir
Journal:  Anatol J Cardiol       Date:  2021-06       Impact factor: 1.596

Review 4.  WHO's in second?: A practical review of World Health Organization group 2 pulmonary hypertension.

Authors:  Sif Hansdottir; Dayna J Groskreutz; Brian K Gehlbach
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

Review 5.  Dasatinib-induced pulmonary arterial hypertension.

Authors:  Nurgül Özgür Yurttaş; Ahmet Emre Eşkazan
Journal:  Br J Clin Pharmacol       Date:  2018-03-06       Impact factor: 4.335

6.  Differential regulation of diacylglycerol kinase isoform in human failing hearts.

Authors:  Olga Bilim; Tetsuro Shishido; Shuji Toyama; Satoshi Suzuki; Toshiki Sasaki; Tatsuro Kitahara; Mitsuaki Sadahiro; Yasuchika Takeishi; Isao Kubota
Journal:  J Cardiothorac Surg       Date:  2011-05-08       Impact factor: 1.637

7.  The Burden of Pulmonary Hypertension in Patients with Degenerative Mitral Valve Disease in Enugu South-East Nigeria: An Echocardiographic Based Study.

Authors:  E C Ejim; N I Oguanobi
Journal:  Ann Med Health Sci Res       Date:  2016 May-Jun

8.  Improved right ventricular function following transapical transcatheter mitral valve implantation for severe mitral regurgitation.

Authors:  Sara Hungerford; Nicole Bart; Paul Jansz; Sharon Kay; Sam Emmanuel; Mayooran Namasivayam; Gry Dahle; Alison Duncan; Christopher Hayward; David W M Muller
Journal:  Int J Cardiol Heart Vasc       Date:  2020-12-16

9.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to left heart disease.

Authors:  Waleed Alhabeeb; Majdy M Idrees; Stefano Ghio; Tarek Kashour
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

Review 10.  Pulmonary hypertension in mitral regurgitation.

Authors:  Harsh Patel; Milind Desai; E Murat Tuzcu; Brian Griffin; Samir Kapadia
Journal:  J Am Heart Assoc       Date:  2014-08-07       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.